Skip to content

Ayurvedic Management of Manyagraha (cervical spondylosis)

â??Randomized Controlled Trial of Vatanashak Ghanavati with Anu Tail Nasya in Manyagraha with special reference to Cervical Spondylosis, specifically on Oswestry Neck Disability Indexâ?¿

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042679
Enrollment
76
Registered
2022-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Sponsors

Self Pranali Ashok Waykar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having signs and symptoms of Manyagraha according to classics. 2. Radiological changes i.e., degenerative changes in cervical vertebrae. 3. The Oswestry neck disability questionnaire, which has been described in criteria of assessment will be taken into account where score >= 10 will be included. 4. Patient with age group 30-70 yrs irrespective of sex, occupation, socio-economic status. 5. Patient willing and able to participate in the study and agrees to fill the consent form. 6. Patients not willing for trial.

Exclusion criteria

Exclusion criteria: History of any fracture of vertebral joint/ surgical/ diagnostic intervention with reference to affected joints will be excluded. 1. The patient who had fix joint or having developed contracture not be included in study. 2. Patient who are not fit for Nasya. 3. Patient with uncontrolled hypertension and uncontrolled diabetes will be ruled out. 4. Patient who have serious and complicated systemic disorders will be excluded. 5. Patient with evidence of malignancy. 6. Patient on prolonged (>=6weeks) medication with corticosteroids, non steroidal anti- inflammatory drug, antidepressants, anti cholinergic etc. or any drugs that may influence on the outcome of the study. 7. Pregnant / lactating women. 8. Patients who had participated in any other clinical trial since last six months.

Design outcomes

Primary

MeasureTime frame
Oral administration of Vatanashak Ghanavati with Anu Tail Nasya is more effective as Erandamula Ghanavati with Anu Tail Nasya in patients of Manyagraha with reference to cervical spondylosis specifically on Oswestry Neck Disability Index.Timepoint: 3 weeks

Secondary

MeasureTime frame
Oral administration of Vatanashak Ghanavati with Anu Tail Nasya is more effective than Erandamula Ghanavati with Anu Tail Nasya in patients of Manyagraha with reference to cervical spondylosis specifically on Oswestry Neck Disability Index.Timepoint: 21 days

Countries

India

Contacts

Public ContactDr Sushil Chawre

Goverment Ayurved College, Nagpur

sushilvilaschawre@gmail.com9923755771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026